Top Managed Healthcare Stocks To Watch For 2014

Regulatory change is high on the agenda at financial services firms, second only to market volatility as a worry among executives, new research from SunGard has found.

Senior executives now worry that changes starting to take effect this year are distracting attention from core business activities and potentially hindering their firms’ ability to grow.

Adapting to new regulations is also causing leaders to rethink their approach to compliance and to restructure their organizations accordingly.

The SunGard survey, which was conducted by Longitude Research in late 2013, polled 400 senior financial services executives across the globe.

The survey found that the pressure of dealing with regulatory change had expanded beyond compliance departments into the corporate suite.

Fifty percent of respondents warned that dealing with regulatory change had affected shareholder returns and the ability to invest for the future.

Forty-six percent of respondents described themselves as “highly stressed” by the current pressure of regulatory change, and saw little prospect of imminent improvement.

5 Best Income Stocks To Invest In 2015: Natural Resource Partners LP (NRP)

Natural Resource Partners L.P. is a limited partnership. The Company is engaged principally in the business of owning, managing and leasing mineral properties in the United States. It owns coal reserves in the three United States coal-producing regions: Appalachia, the Illinois Basin and the Western United States, as well as lignite reserves in the Gulf Coast region. The Company is engaged in the ownership and leasing of mineral properties and related transportation and processing infrastructure. As of December 31, 2011, the Company owned or controlled approximately 2.3 billion tons of proven and probable coal reserves and it also owned approximately 380 million tons of aggregate reserves in a number of states across the country. During the year ended December 31, 2011, its lessees produced 49.2 million tons of coal from its properties. In addition, the Company�� lessees produced 49.2 million tons of coal from its properties. The Company�� operations are conducted through, and its operating assets are owned by, its subsidiaries. The Company owns its subsidiaries through a wholly owned operating company, NRP (Operating) LLC. NRP (GP) LP, which is its general partner, which conducts its business and manages its operations. Because its general partner is a limited partnership, its general partner, GP Natural Resource Partners LLC, conducts its business and operations. Robertson Coal Management LLC owns all of the membership interest in GP Natural Resource Partners LLC. In addition to its preparation plants, the Company owns coal handling and transportation infrastructure in West Virginia, Ohio and Illinois. In February 2011, it acquired approximately 500 acres of mineral and surface rights related to limestone reserves on the Tennessee River near Paducah, Kentucky. In March 2011, it acquired approximately 500 acres of mineral and surface rights related to limestone reserves in Cleveland, Tennessee near Chattanooga. In July 2011, it acquired approximately 44,000 acres of coal reserves and coal bed met! hane located in Pennsylvania and Illinois. In February 2012, the Company acquired coal reserves at the Deer Run mine near Hillsboro, Illinois and approximately 9,500 net mineral acres located in the Mississippian Lime oil play in Northern Oklahoma. In March 2012, the Company acquired the rail loadout, associated infrastructure assets and a contractual overriding royalty interest on certain tonnage at the Sugar Camp mine near Benton, Illinois. In May 2012, the Company completed the acquisition of approximately 19,200 net mineral acres in the Mississippian Lime oil play in North Central Oklahoma.

Northern Appalachia

The Beaver Creek property is located in Grant and Tucker Counties, West Virginia. During 2011, 2.4million tons were produced from this property. The Company leases this property to Mettiki Coal, LLC, which is a subsidiary of Alliance Resource Partners L.P. Coal is produced from an underground longwall mine. It is transported by truck to a preparation plant operated by the lessee. Coal is shipped primarily by truck to the Mount Storm power plant of Dominion Power and to various export customers. During 2011, 366,000 tons were produced from Allegany County. The Company leases this property to Vindex Energy, a subsidiary of Arch Coal. Coal from this property is produced from a surface mine. The raw coal is trucked to the Warrior plant of Allegheny Energy. During 2011, 283,000 tons were produced from Area F property. It leases this property to Carter Roag, a subsidiary of Metinvest. Coal from this property is produced from an underground mine. The raw coal is trucked to a preparation plant operated by the lessee. Coal is shipped via rail to domestic metallurgical customers and exported for use by Metinvest.

Central Appalachia

The VICC/Alpha property is located in Wise, Dickenson, Russell and Buchanan Counties, Virginia. During 2011, 4.9 million tons were produced from this property. It primarily leases this property to a subsidiary of Alpha Natu! ral Resou! rces. Production comes from both underground and surface mines and is trucked to one of four preparation plants. Coal is shipped through both the CSX and Norfolk Southern railroads to utility and metallurgical customers. Customers include American Electric Power, Southern Company, Tennessee Valley Authority, VEPCO and the United States Steel and to various export metallurgical customers. The Lynch property is located in Harlan and Letcher Counties, Kentucky. During 2011, 4.8 million tons were produced from this property. The Company primarily leases the property to a subsidiary of Massey Energy. Production comes from both underground and surface mines. Coal is transported by truck to a preparation plant on the property and is shipped primarily on the CSX railroad to utility customers, such as Georgia Power and Orlando Utilities.

The Dingess-Rum property is located in Logan, Clay and Nicholas Counties, West Virginia. This property is leased to subsidiaries of Massey Energy and Patriot Coal. During 2011, 2.8 million tons were produced from the property. Coal is shipped through the CSX railroad to steam customers, such as American Electric Power, Dayton Power and Light, Detroit Edison and to various export metallurgical customers.

The VICC/Kentucky Land property is located primarily in Perry, Leslie and Pike Counties, Kentucky. During 2011, 2.5 million tons were produced from this property. Coal is produced from a number of lessees from both underground and surface mines. Coal is shipped primarily by truck but also on the CSX and Norfolk Southern railroads to customers, such as Southern Company, Tennessee Valley Authority and American Electric Power. The Lone Mountain property is located in Harlan County, Kentucky. During 2011, 2.1 million tons were produced from this property. The Company leases the property to a subsidiary of Arch Coal, Inc. Production comes from underground mines and is transported primarily by beltline to a preparation plant on adjacent property and shipped o! n the Nor! folk Southern or CSX railroads to utility customers, such as Georgia Power and the Tennessee Valley Authority.

The D.D. Shepard property is located in Boone County, West Virginia. This property is primarily leased to a subsidiary of Patriot Coal Corp. During 2011, two million tons were produced from the property. Both steam and metallurgical coal are produced by the lessees from underground and surface mines. Coal is transported from the mines through belt or truck to preparation plants on the property. Coal is shipped through the CSX railroad to various domestic and export metallurgical customers. The Pardee property is located in Letcher County, Kentucky and Wise County Virginia. During 2011, 1.8 million tons were produced from this property. It leases the property to a subsidiary of Arch Coal, Inc. Production comes from underground and surface mines and is transported by truck or beltline to a preparation plant on the property and shipped primarily on the Norfolk Southern railroad to utility customers, such as Georgia Power and the Tennessee Valley Authority and domestic, and export metallurgical customers, such as Algoma Steel and Arcelor.

The Kingston property is located in Fayette and Raleigh Counties, West Virginia. This property is leased to a subsidiary of Alpha Natural Resources. During 2011, 1.5 million tons were produced from the property. Both steam and metallurgical coal are produced from underground and surface mines and has been historically transported by belt or truck to a preparation plant on the property or shipped raw. Coal is shipped via both the CSX railroad and by truck to barges to steam customers and various export metallurgical customers.

Southern Appalachia

The BLC properties are located in Kentucky and Tennessee. During 2011, 1.2 million tons were produced from these properties. The Company leases these properties to a number of operators, including Appolo Fuels Inc., Bell County Coal Corporation and Kopper-Glo Fuels. Prod! uction co! mes from both underground and surface mines and is trucked to preparation plants and loading facilities operated by its lessees. Coal is transported by truck and is shipped through both CSX and Norfolk Southern railroads to utility and industrial customers. Customers include Southern Company, South Carolina Electric & Gas, and numerous medium and small industrial customers. The Oak Grove property is located in Jefferson County, Alabama. During 2011, 470,000 tons were produced from this property. The Company leases the property to a subsidiary of Cliffs Natural Resources, Inc. Production comes from an underground mine and is transported primarily by beltline to a preparation plant. The metallurgical coal is then shipped through railroad and barge to both domestic and export customers.

Illinois Basin

The Williamson property is located in Franklin and Williamson Counties, Illinois. The property is under lease to an affiliate of the Cline Group. During 2011, 6.8 million tons were mined on the property. This production is from a longwall mine. Production is shipped primarily through CN railroad to customers, such as Duke and to various export customers. The Macoupin property is located in Macoupin County, Illinois. The property is under lease to an affiliate of the Cline Group. During 2011, 1.8 tons were shipped from the property. Production is from an underground mine and is shipped through the Norfolk Southern or Union Pacific railroads or by barge to customers, such as Western KY Energy and other midwest utilities or loaded into barges for shipment to export customers. The Sato property is located in Jackson County, Illinois. During 2011, 363,000 tons were produced from the property. The property is under lease to Knight Hawk Coal LLC, an independent coal producer. As of December 31, 2011, production was from a surface mine, and coal was shipped by truck and railroad to various midwest and southeast utilities.

Northern Powder River Basin

The Western Ener! gy proper! ty is located in Rosebud and Treasure Counties, Montana. During 2011, 2.7 million tons were produced from the Company�� property. A subsidiary of Westmoreland Coal Company has two coal leases on the property. Coal is produced by surface dragline mining, and the coal is transported by either truck or beltline to the four-unit 2,200-megawatt Colstrip generation station located at the mine mouth and by the Burlington Northern Santa Fe railroad to Minnesota Power. A small amount of coal is transported by truck to other customers.

BRP Properties

As of December 31, 2011, BRP had acquired, in several stages, approximately 8.8 million mineral acres in 29 states from International Paper. As of December 31, 2011, BRP held 78 revenue generating leases. BRP�� assets include approximately 300,000 gross acres of oil and gas mineral rights in Louisiana, of which over 72,000 acres were under lease, as of December 31, 2011. In addition, BRP holds a gross production royalty interest on approximately 23,000 mineral acres under lease in Louisiana. The remaining oil and gas mineral acreage in Louisiana is not leased. As of December 31, 2011, BRP owned nearly 246,000 gross mineral acres of primarily lignite coal rights in the Gulf Coast region, of which approximately 5,000 acres are leased under three separate leases in Louisiana and Alabama. In addition to the coal rights, BRP held aggregate reserves, including limestone, granite, clay, and sand and gravel reserves, under lease in six states. As of December 31, 2011, other mineral rights held by BRP included coalbed methane rights in four Gulf Coast states, metals rights in three states, approximately 450,000 acres of water rights in East Texas, geothermal rights and royalty interests in the Gulf Coast and Pacific Northwest and carbon sequestration rights primarily in the Gulf Coast region.

Advisors' Opinion:

• [By Robert Rapier]

  Rounding out the bottom five were�OCI Partners�(NYSE: OCIP), a methanol and ammonia producer (-24 percent YTD),�Natural Resource Partners�(NYSE: NRP), another coal producer (-19 percent), and�Eagle Rock Energy Partners�(NASDAQ: EROC), an oil and gas production partnership (-17 percent).

• [By Tyler Crowe]

  In the energy world, it's never much of a surprise when an oil company picks up natural gas assets or vice versa. But a coal company getting into the oil business? Now that's a rarity. This week, Natural Resources Partners (NYSE: NRP  ) �did just that. The company announced that it's taking a working interest in some of Abraxas Petroleums (NASDAQ: AXAS  ) assets in the Bakken. While the $35 million purchase was not that large, it's a rare case where a coal company branches out into other natural resources.�

• [By Robert Rapier]

  The National Association of Publicly Traded Partnerships (NAPTP) lists five MLPs in the category ��atural Resources – Coal,��although two of the five are Alliance Holdings (NYSE: AHGP) and its operating affiliate, Alliance Resource Partners (NYSE: ARLP). The other three are Natural Resource Partners (NYSE: NRP), Rhino Resource Partners (NYSE: RNO), and Oxford Resource Partners (NYSE: OXF).

Top Managed Healthcare Stocks To Watch For 2014: Reynolds American Inc(RAI)

Reynolds American Inc. (RAI), through its subsidiaries, manufactures and sells cigarette and other tobacco products in the United States. It offers cigarettes under the brand names of CAMEL, PALL MALL, WINSTON, KOOL, DORAL, SALEM, MISTY, and CAPRI; and cigarettes and other tobacco products under the NATURAL AMERICAN SPIRIT brand name, as well as manages various licensed brands, including DUNHILL and STATE EXPRESS 555. The company also provides smokeless tobacco products, including moist snuff under GRIZZLY and KODIAK brand names; pasteurized tobacco under CAMEL Snus brand name; milled tobacco under the brand name of CAMEL Dissolvables; other tobacco products, such as little cigars under WINCHESTER and CAPTAIN BLACK brand names; and roll-your-own tobacco under the brand name of BUGLER. RAI sells its products primarily through distributors, wholesalers, and other direct customers, including retail chains, as well as distributes its cigarettes to public warehouses. The compan y was founded in 1875 and is headquartered in Winston-Salem, North Carolina.

Advisors' Opinion:

• [By Ben Popkin]

  The recent launches
  While Lorillard has the leading e-cigarette, other major tobacco companies like�Reynolds American (NYSE: RAI  ) and Altria (NYSE: MO  ) have begun making versions of their own.

• [By Patricio Kehoe] >Lorillard Inc. (LO). In addition to the popularity of its brands, Phillip Morris benefits from scale advantages, combined with the historically strong brand loyalty among smokers, earning the firm strong pricing power. This advantage has allowed revenue to nearly double since 2006, leaving its current level of $77.4 billion.

  Regarding Taxes, Regulations and Margins

  Despite recent anti-tobacco laws passed by the European Union and the Food and Drug Administration (FDA) in the U.S, the company�� pricing power has helped maintain its margins. In 2012, for example, Phillip Morris hiked prices on its products in Russia, Germany, Belgium, Canada, France, Greece and Spain, among others. Although the necessary measure caused substantial volume declines in these countries, consumers rapidly became accustomed to the increased prices, and returned to their habitual product consumption. Given the success of this strategy, the firm is likely to rely on it in Japan for 2014, where taxes are expected to increase yet again by 8%, after the 40% spike in October 2010.

  Another profitable business opportunity may come from the company�� recent cross-licensing agreement with its parent firm Altria, regarding next-generation products. The deal will allow Phillip Morris to market Altria�� eCig products outside the U.S, while the parent firm commercializes the tobacco giant�� two heated tobacco products, Platform 1 and Platform 2, within the U.S. Platform 1 is meant to launch in 2014, and Platform 2 a year later, which should help the company branch out to changing consumer habits among smokers and generate further revenue. On another note, Phillip Morris��shareholder returns should not pass unseen by investors. Since 2008, the company has returned $59.1 billion to its investors via share repurchases ($27.9) and dividends ($24), and currently holds a steady dividend yield of 4.39%.

  Bottom Line

  With an EPS growth of 16.90%���well above the in

• [By Shauna O'Brien]

  On Friday, tobacco company Reynolds American, Inc. (RAI) reported a public offering of $1.1 billion aggregate principal amount of senior notes.

  The notes include $500 million aggregate principal amount of 4.850% Senior Notes due 2023 and $550 million aggregate principal amount of 6.150% Senior Notes due 2043.

  RAI plans to use the funds obtained from the notes to buy back $200 million of the outstanding principal amount of its 7.300% notes due in 2015 and the $775 million outstanding principal amount of notes due in 2016.

  Reynolds American shares were mostly flat during pre-market trading Friday. The stock is up 16% YTD.

Top Managed Healthcare Stocks To Watch For 2014: Canadian Utilities Ltd (CDUAF)

Canadian Utilities Limited is a holding company. The Company is engaged in Utilities (pipelines, natural gas and electricity transmission and distribution), Energy (power generation, natural gas gathering, processing, storage and liquids extraction), and Technologies (business systems solutions). The Company operates in threes segments: TCO Electric, ATCO Gas and ATCO Pipelines. ATCO Electric is engaged in the regulated business of transmitting and distributing electricity to 245 communities as well as rural areas in east-central and northern Alberta. ATCO Gas is engaged in the business of distributing natural gas throughout Alberta and in the Lloydminster area of Saskatchewan. ATCO Pipelines is a regulated business engaged in the transmission of natural gas in Alberta. ATCO Pipelines receives natural gas on its pipeline system at various gas processing plants and transports it to end users within the province or other pipeline systems for export out of the province. Advisors' Opinion:

• [By John Heinzl]

  Contrast that with a company such as Canadian Utilities (CDUAF), whose eight price targets range from $40 to $42. (The stock closed Friday at $38.08 [Canadian]). Such tight clustering of targets indicates that analysts have a high degree of conviction about the company's future earnings, which isn't surprising for a utility that throws off predictable cash flows.

Top Managed Healthcare Stocks To Watch For 2014: The Medicines Company(MDCO)

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention; and Cleviprex, an intravenous small molecule calcium channel blocker for the reduction of blood pressure, as well as to treat neurocritical care and cardiac surgery patients. Its products under development include Cangrelor that is in Phase III clinical trial acts as an intravenous small molecule antiplatelet agent to prevent platelet activation and aggregation; and Oritavancin, which is in Phase III clinical trial acts as an investigational intravenous antibiotic for the treatment of serious gram-positive bacterial infections, including acute bacterial skin and skin structure infections. The company?s products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS), and patients experiencing myocardial infarction, stroke, or peripheral arterial disease; MDCO-2010, a small molecule serine protease inhibitor that is in Phase II clinical trial used for the reduction of blood loss during surgery; and MDCO-216, which is in Phase I clinical trial used for the reversal of atherosclerotic plaque development and the reduction of the risk of coronary events in patients with ACS. Its products also consist of Argatroban, a direct thrombin inhibitor used as anticoagulant for prophylaxis or for the treatment of thrombosis; and acute care generic products. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Advisors' Opinion:

• [By Lisa Levin]

  The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

• [By Jay Silverman]

  The Medicines Company (MDCO) is delivering on its plan to become the leading acute care provider of medicines in the hospital setting—in acute cardiovascular care, surgical, and perioperative medicine, and hospital-based infectious disease.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drug developer The Medicines Company (NASDAQ: MDCO  ) has earned a respected four-star ranking.

Top Managed Healthcare Stocks To Watch For 2014: Elan Corporation PLC (ELN)

Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.

Tysabri

Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.

In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.

Beta Amyloid Immunotherapies (AIP)

Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).

ELND005, an A� Aggregation Inhibitor

The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.

Neotope Biosciences Limited

Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.

Onclave Therapeutics Limited

Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.

The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.

Advisors' Opinion:

• [By WALLSTCHEATSHEET]

  Elan is a biotechnology company that is looking for ways to improve and better the lives of people with disruptive diseases. The company is now set to be bought-out by Perrigo. The stock has been rising over the last several months, and is now trading at prices not seen for five years. Over the last four quarters, investors have had mixed feelings about the company, as earnings have been mixed, while revenue figures have been improving. Relative to its peers and sector, Elan has been a year-to-date performance leader. Look for Elan to OUTPERFORM.

Top Managed Healthcare Stocks To Watch For 2014: Apollo Group Inc.(APOL)

Apollo Group, Inc., through its subsidiaries, provides online and on-campus educational programs and services at the undergraduate, master?s, and doctoral levels. The company offers various degree programs in arts and sciences, business and management, criminal justice and security, education, health care, human services, nursing, psychology, and technology through its campus locations and learning centers in 40 states and the District of Columbia, and Puerto Rico, as well as through its online education delivery system. It also provides various degree programs in Chile and Mexico, and through online; financial services education programs, including Master of Science in three majors, as well as certification programs in retirement, asset management, and other financial planning areas; and training and education to professionals in the legal and finance industries through its schools in the United Kingdom and a network of offices in Europe. In addition, the company offers p rogram development, administration, and management consulting services comprising degree program design, curriculum development, market research, student admissions, and accounting and administrative services to private colleges and universities for their working learners? programs; and sells books and other publications. Apollo Group, Inc. was founded in 1973 and is based in Phoenix, Arizona.

Advisors' Opinion:

• [By Matt Thalman]

  Another big loser was the Apollo Group (NASDAQ: APOL  ) , which lost 10.27% of its value today. The company announced earnings yesterday after the market closed, and although it beat the Street's estimates for adjusted profit, its revenue misses expectations. For the quarter, revenue was down 16% as enrollment for the company's for-profit education unit, The University of Phoenix, fell 17% to 287,500 students. Apollo also announced that it expects revenue to come in at $3.65 billion to $3.7 billion for the full 2013 year while analysts had pinned the number to be higher at $3.71 billion. �

• [By Jeremy Bowman]

  What: Shares of Education Management Corporation (NASDAQ: EDMC  ) and Apollo Group (NASDAQ: APOL  ) were headed to the top of the class today, gaining as much as 10% on a strong day for for-profit educators.

• [By Ben Levisohn]

  Shres of Corinthian have dropped 4.2% to $1.96 but don’t seem to be hitting other for profit universities. ITT Educational Services (ESI) has gained 2.2% to $31, Apollo Group (APOL) has risen 0.7% to $20.44 and Devry (DV) is up 0.9% at $31.95.